Levi & korsinsky investigates possible securities fraud violations by west pharmaceutical services, inc. (wst)

New york, ny / access newswire / april 18, 2025 / levi & korsinsky notifies investors that it has commenced an investigation of west pharmaceutical services, inc. ("west pharmaceutical services, inc.") (nyse:wst) concerning possible violations of federal securities laws. on february 12, 2025, west reported positive 4q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
WST Ratings Summary
WST Quant Ranking